?> Contact us Follow Us
Biosimilars Forum
  • About Us
    • Members
    • Executive Director
  • Why Biosimilars
    • The Issue
    • Our Solutions
  • Biosimilars 101
    • Foundations
    • Core Principles
    • FDA Regulatory Tenets
    • Biosimilars FAQs
    • Future Evolution of Biosimilar Development
    • Approved Biosimilars
  • Advocacy
    • Our Action
    • Tools
  • News
  • Resources
  • Get Involved
    • Partners

News

Get more out of your business.
Reach it with Microsoft Dynamics 365 Business Central.
News
October 10, 2018 Katie Quinn
New White Paper Finds Biosimilars Could Drive Greater Value Beyond Price for Healthcare System
News
August 9, 2018 Katie Quinn
Biosimilars Forum Statement on CMS Announcement Regarding Medicare Advantage
News
July 18, 2018 Katie Quinn
Biosimilars Forum Applauds Biosimilars Action Plan Released by FDA Commissioner Scott Gottlieb
News
July 16, 2018 Katie Quinn
Biosimilars Forum Submits Comments on HHS Blueprint to Lower Drug Prices
News
July 12, 2018 Katie Quinn
Biosimilars Forum Commends FDA Commissioner For Raising Awareness Of Biosimilars
News
July 9, 2018 Katie Quinn
Biosimilars Forum Convenes Stakeholder Groups to Discuss Advancing Biosimilars
News
June 27, 2018 Katie Quinn
Biosimilars Forum Releases Position on Non-Medical Switching
News
June 21, 2018 Katie Quinn
Biosimilars Forum Applauds FDA Decision to Reevaluate Draft Guidance
News
May 16, 2018 Katie Quinn
Biosimilars Forum Applauds Approval of 10th Biosimilar in United States
News
May 11, 2018 Katie Quinn
Biosimilars Forum Encouraged by Trump Administration’s Support for Biosimilars
  • Prev page
  • 14
  • 15
  • 16
  • 17
  • 18
  • Next page

  • Biosimilars 101
  • Biosimilars FAQs
  • Advocacy
  • Stay Connected
Biosimilars Forum
© 2025 Biosimilars Forum. All rights reserved.
  • Terms of Use
  • |
  • Privacy Policy
  • |
  • Contact Us